Joe Yeong
Group Leader, A*STAR - Agency for Science Technology and Research
Revolutionizing Solid Tumor Treatments in 2024: Combining Approaches for Effective Targeting and Optimised CAR-T Strategies for Increased Patient Benefits
9:00 am
Session Details to Be Confirmed
Christy Ma
Chief Executive Officer, SCG Cell Therapy
9:30 am
Harnessing Immune Cell Therapies for Better Clinical Efficacy Against Solid Tumors
4:30 pm
Gaining Strategic Investments for Cell Therapy Innovations from Venture Lenders & Investors: From Bedside to Bankside, From Wallstreet to Mainstreet
Yang Liu
Vice President & Venture Partner, China Credit Enhancement Corporation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok